Microbes Infect. 2010;12:113-18.
30 Leitmeyer K, Vaughn D, Watts DM, Salas R, Villalobos de Chacon I, Dengue virus structural differences that correlate with patogénesis. J Virol. 1999 Jun;73(6):4738-47.
31- Cologna R, Armstrong PM, Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol. 2005;79:853-9.
32-Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol. 2003;3:19-28.
33- World Health Organization, 2009 Dengue: Guidelines for Diagnosis, Treatment,
Prevention and Control (Directrices para el diagnóstico, tratamiento, prevención y control). Geneva: World Health Organization
34- Pan American Health Organization. Guide for diagnosis, treatment and control of dengue hemorrhagic fever for the South East Asian and Westerns Pacific Region, Ginebra, 1986:7.
35- Kourí G, Guzmán MG, Bravo J. Dengue hemorrágico en Cuba: crónica de una epidemia. Bol Of Sanit Panam 1986;100(3):322-9.
36- Kourí G, Mas P, Guzmán MG, Soler M, Goyenechea A, Morier L. Dengue Hemorrágico en Cuba en 1981. Diagnóstico rápido del agente etiológico. Bol Of Sanit Panam 1982;93(5):414-20.
37- Guzmán MG, García G, Kourí G. El dengue y el dengue hemorrágico: prioridades de investigación. Rev Panam Salud Pública.2006;19(3):204-13.
38- Corrales-Aguilar E, Hun-Opfer L. Nuevas perspectivas sobre la patogénesis del dengue. Acta Méd Costarric [Internet]. 2012 Jun [citado 24 Nov 2012];54(2):75-85. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022012000200003&lng=es
39- Thomas L, Verlaeten O, Cabie A, Kaidomar S, Moravie V, Martial J, et al. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg. 2008;78:990-98.
40- Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22:564-81
41- McLinden JH, Stapleton JT, Chang Q, Xiang J. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis. 2008;198:860-63.
42- Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, et al. Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4(+) Cells. J Immunol. 2009;183:7860-69.
43- Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, Rocha C, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology. 2008 Jul 5;376(2):429-35.
44- Limonta D, Capo V, Torres G, Pérez AB, Guzmán MG. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol. 2007;40:50-4.
45- Simmons CP, Farrar JJ, Van Vinh Chau N, Bridget W. Dengue fever. N Engl J Med. 2012;366:1423-32.
46- Guzmán M, Álvarez A, Fuentes O, Kourí G. Enfermedades de la pobreza. El caso del dengue. Ann Acad Cienc Cuba [Internet]. 2012 Nov [citado 2 Dic 2012];2(1):10-22. Disponible en: http://www.revistaccuba.cu/index.php/acc/article/view/109/91
47- Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100 –3.
48- Organización Mundial de la Salud (OMS). Programa Especial para Investigación y Capacitación en Enfermedades Tropicales (TDR). Dengue: guías para el diagnóstico, tratamiento, prevención y control- 2009. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2009.
49- Espina LM, Valero NJ, Hernández JM, Mosquera JA. Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg. 2003;68:48-53.
50- Lim WK, Mathur R, Koh A, Yeoh R, Chee SP. Ocular manifestations of dengue fever. Ophthalmology. 2004 Nov;111(11):2057–64
51- Emerg Infect Dis 2007 Apr;13(4):650
52- Indian J Dermatol 2010;55(1):79
53 – Indian J Dermatol 2010;55(1):79
54- Ophthalmologica 2008;222(5):317
55- Pediatr Infect Dis J 2007 Apr;26(4):283
56- Trop Med Int Health 2002 Feb;7(2):125
57- Dr. Daniel González Rubio; Description of dengue hemorrhagic fever, serotype 3, City of Havana, 2001-2002, 2(1):10-22.
58- (Int J Infect Dis 1999 Spring;3(3):130
59- (Am J Trop Med Hyg 1988 Jan;38(1):172)
60- Vargas Vargas L, Bustillos de Núñez G. Técnicas participativas para la educación popular. Chile: CIDE;1990.
61- Rigau-Pérez JC. Puerto Rico Association of Epidemiologists: Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Rev Panam Salud Pública. 1997;1:381-88.
62- Zagne SMO, Alves VGF, Nogueira RMR. Dengue hemorrhagic fever in the state of Rio de Janeiro, Brazil: A study of 56 confirmed cases. Trans R Soc Trop Med Hyg. 1994;88:667-79.
63-. Bravo JR, Guzmán MG, Kourí GP. Why dengue hemorrhagic fever in Cuba?:1: individual risk factors for dengue hemorrhagic fever/ dengue shock syndrome (DHF/ DSS). Trans R Soc Trop Med Hyg. 1987;81:816-20.
64- Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology. 1999;257:1-6.
65- Diab Vasc Dis Res 2008 Sep;5(3):213 PDF
66- PLoS Negl Trop Dis 2010 Jun 1;4(6):e699 fulltext.
67- Int J Infect Dis 2007 May;11(3):263
68- J Microbiol Immunol Infect 2006 Apr;39(2):121
69- Guzmán MG, Kourí G, Martínez E, Bravo J, Riverón R, Soler M, et al. Fiebre hemorrágica del dengue con síndrome de choque en niños cubanos. Bol Of Sanit Panam 1998;104(3):235-43.